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Background: Metabolic syndrome (MetS) is a clustering of cardiovascular risk factors, which is associated with
diabetes mellitus and cardiovascular disease. Lifestyle interventions applied to people with MetS has considerable
beneficial effects on disease preventive outcomes. This study aimed to examine the effects of 1-year of yoga exercise
on the cardiovascular risk factors including central obesity, hypertension, dyslipidemia and hyperglycemia in
middle-aged and older Hong Kong Chinese adults with MetS.
Methods: Adults diagnosed with MetS using National Cholesterol Education Program criteria (n = 182; mean ± SD
age = 56 ± 9.1) were randomly assigned to a 1-year yoga intervention group or control group. Systolic and diastolic
blood pressure, waist circumference, fasting plasma glucose, triglycerides, and high-density lipoprotein cholesterol were
examined at baseline, midway, and on completion of the study. Physical activity level and caloric intake were assessed
and included in the covariate analyses.
Results: A reduction of the number of diagnostic components for MetS was found to be associated with the yoga
intervention. Waist circumference was significantly improved after the 1-year yoga intervention. A trend towards a
decrease in systolic blood pressure was observed following yoga intervention.
Conclusion: These results suggest that yoga exercise improves the cardiovascular risk factors including central
obesity and blood pressure in middle-aged and older adults with MetS. These findings support the complementary
beneficial role of yoga in managing MetS.
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Metabolic syndrome (MetS) refers to a clustering of car-
diovascular risk factors, including high blood pressure,
central obesity, insulin resistance and dyslipidemia, that
has become a global public health epidemic. MetS repre-
sents a pre-diabetic and pre-cardiovascular pathological
condition, and could be taken as a useful tool in prognos-
ing development of cardiovascular disease and diabetes
mellitus [1-5]. Most importantly, lifestyle modification in-
terventions applied at the pre-pathologic stage signified by
MetS could be of considerable health benefit and clinical
significance, achieving better preventive and therapeutic* Correspondence: parco.siu@polyu.edu.hk
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unless otherwise stated.outcomes in regard to diabetes and cardiovascular dis-
ease [4,6]. Indeed, lifestyle modification has been sug-
gested to be the cornerstone for successful management
of MetS [6,7].
Yoga is a mind-body exercise which comprises medita-
tion, breathing and body posture [8]. Hatha yoga, a
branch of yoga that is most widely practiced, consists of
manipulation of respiration (pranayama) and posture
control (asana). In addition to voluntary active control
of abdominal breathing, Hatha yoga intends to develop a
stable and effortless body position by coordinating pos-
ture which involves balancing and stretching [9]. Indeed,
yoga has been shown to decrease stress [10], reduce de-
pression and anxiety, and increase the perceived self-
efficacy in healthy individuals [11,12]. In addition to the
beneficial psychological effects, yoga has also beens is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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cular risk factors. A randomized case control study has
demonstrated that 3-month of yoga intervention induces
significant improvements of MetS parameters including
waist circumference, systolic/diastolic blood pressure, fast-
ing blood sugar level, HbA1c, serum triglyceride and high-
density lipoprotein-cholesterol in middle-aged adults [13].
Another randomized controlled pilot study has further
illustrated the feasibility and acceptability of yoga inter-
vention in sedentary overweight adults aged ~52 years
with MetS [14]. Their data indicated that 10-week of yoga
intervention increases energy level, tends to lower blood
pressure and improve psychological well-being and perceived
stress [14]. Nevertheless, we lack objective scientific evidence
from randomized trials of adequate sample size and a suffi-
ciently long experimental period to show the beneficial ef-
fects of yoga in managing MetS, particularly in the older
population. This study therefore aimed to assess the effects
of a 1-year yoga programme on MetS diagnostic parameters
as the primary outcome measures in middle-aged and older
adults who were already diagnosed with MetS. The effects of
yoga on depression and perceived quality of life were
also examined as the secondary outcome measures. We
tested the hypothesis that 1-year yoga intervention im-
proves the MetS diagnostic parameters in middle-aged
and older adults with MetS.
Methods
Study design, settings and subject recruitment
The present study was a randomized controlled, parallel,
open label trial in patients with MetS conducted in one
center in Hong Kong between November 2010 and Aug
2013. Adults with age between 30 and 80, diagnosed
with MetS using National Cholesterol Education Pro-
gram (NCEP) criteria (n = 182; mean ± SD age = 56 ± 9.1)
were randomly assigned to a 1-year yoga intervention
group or control group. During the 1-year experimental
period, subjects attended three measurement sessions,
which were the baseline measurement right after being
recruited to the study (Pre), mid-term follow-up at six
months after the study started (Mid), and the final meas-
urement upon completion of the 1-year experimental
period (Post). The schematic study flowchart is pre-
sented in Figure 1. Power analysis was conducted to esti-
mate the sample size needed. With α = 0.05, β = 0.2 and
moderate effect size (0.25 standard deviation), total of 86
subjects were needed (43 subjects in each group).
In this study, 3,967 Chinese participants aged from 18
to 94 voluntarily recruited from the community were
screened for MetS between 2010 to 2012 on the basis of
the diagnostic guideline of the United States National
Cholesterol Education Program (NCEP) Expert Panel
Adult Treatment Panel (ATP) III criteria, in which an
individual diagnosed with MetS has three or more offollowing characteristics: 1) central obesity (waist circum-
ference exceeds 90 cm or 80 cm for Asian male and fe-
male, respectively), 2) hypertension (systolic pressure
equals or exceed 130 mmHg or diastolic pressure equals
or exceeds 85 mmHg), 3) elevated blood glucose (fasting
glucose level equals or exceeds 5.5 mmol/L [100 mg/dL]),
4) elevated plasma triglycerides (level equals or exceeds
1.70 mmol/L [150 mg/dL]), and 5) low level of high-
density lipoprotein-cholesterol (HDL-C; level equals or is
less than 40 mg/dL for male and 50 mg/dL for female) [5].
Participants were informed about the potential risks and
benefits of their participation, and written informed con-
sent was obtained on a voluntary basis before the study
began. All the experimental procedures received human
research ethics approval from The Hong Kong Polytechnic
University (ethics approval number: HSEARS20090820001).
Participants who were not in the age range from 30 to
80 or reported having dementia or mental disorder, severe
cardiovascular illness, previous stroke, neuromusculoske-
letal illness, diagnosed major orthopaedic problems in the
lower back, pelvis or lower extremities, severe rheumatoid
arthritis or osteoarthritis, pulmonary illness, or who were
immobile or used a wheelchair, on drug therapy treating
metabolic abnormalities, had symptomatic heart or lung
disease, or other physical conditions not suitable for yoga
exercise were excluded. In addition, regular tobacco users
and subjects who exercised regularly (three or more days
a week in which they had moderate-to-vigorous exercise
of duration of at least 30 minutes per session) were ex-
cluded. Randomization and allocation to trial group were
conducted by a computer program. In this study, 283 adults
participants were randomized, and assigned to control
group and yoga group (Control Group n = 137, Yoga Group
n = 146) and 182 participants finally completed the study
(Control Group n = 98, Yoga Group n = 84) (Figure 2).Intervention
Among the screened participants, suitable subjects diag-
nosed with MetS were invited to participate in our yoga
intervention study. A computer program which could
randomly generate the group names was employed to
allocate the suitable participants to control and yoga
groups. Subjects in control group were contacted
monthly by telephone to assess their health status by
questionnaire and monitored throughout the study.
Subjects in yoga group were assigned to 1-year of yoga
program following a published protocol with custom-
ized modifications for yoga beginners and senior indi-
viduals [15]. Subjects in the yoga group who failed to
achieve 70% attendance to the training program were
excluded from the study. All subjects were asked to ad-
here to their habitual daily dietary intake and other
physical activities throughout the experimental period.
Figure 1 Schematic presentation of the study work flow.
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Yoga intervention
Participants in the yoga group attended three yoga ses-
sions weekly for 1 year. Each session lasted for 60-min
consisting of 10-min of warm-up, 40-min of Hatha yoga
practice, and 10-min of breathing exercise and relaxation.
The postures in the routine training protocol including
sukhasana (easy pose), child pose, cat and cow stretch,
adho muha svanasana (downward dog), high lunge, utta-
nasana (standing forward bend), mountain pose, uradva
hastasana (upward salute), ukatassanna (chair pose),virabhadrasana (worrior pose), utthita parsva konasana
(side angle pose), utthita trikonasana (extended triangle
pose), vrksasana (tree pose), malasana (garland pose), eka
pada rajakapotasana (one legged king pigeon pose), sal-
ambhasana (locust pose), dandasana (staff pose), baddha
konasana (bound angle pose), agnistambhasana (fire log
pose), gomukhasana (cow face pose), spinal twist, pari-
purna navasana (knees bend version of boat pose), setu
bandhasana (bridge pose), supta padangusthasana (reclin-
ing big toe pose), ananda balsana (happy baby pose), cen-
tering (in cross-legged position), finger and toe weaving,
virasana (hero pose), vajrasana (thunderbolt pose), ta-
dasana (mountain pose), table pose (e.g., leg lifts),
Figure 2 Schematic presentation of the study.
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pose), sputa padangusthana (big toe lying down pose),
uttitha hasta padangustasana (extended big toe pose),
sputa baddha konasana (lying down bound angle pose),
eka pada bhekasana (1-leg frog pose), and shavasana
(corpse pose). All these postures have been reported to
be suitable for yoga beginners and senior individuals
[15]. Subjects were encouraged, but not required, to
complete all the tasks. All yoga classes were operated
by certified yoga instructors who had at least 5 years of
yoga teaching experience. The intensity of yoga exer-
cise was determined by the instructors in order to pro-
vide a progressive level of challenge to the subjects.
The performance of the subject was continuously and
closely monitored by the attending yoga instructor.
Adjustment of the intensity of yoga exercise was made
according to the judgement of instructor in order to
maintain the appropriate challenge for the subjects.Outcomes measurements: MetS parameters and blood
biochemistry
In each measurement session, subjects of yoga and con-
trol groups were assessed for the NCEP-defined MetS
diagnostic parameters (including blood pressure, waist
circumference, fasting glucose, triglycerides, and HDL-C)
and were requested to complete a battery of question-
naires including Center for Epidemiologic Studies Depres-
sion Scale (CES-D), the 12-item Short-form health survey
(SF-12), and the International Physical Activity Question-
naire (IPAQ). At the Pre and Post measurement sessions,
subjects were also requested to provide information of a
3-day weighed dietary record which included two week-
days plus one day during the weekend.
Cardiovascular measurements including systolic blood
pressure, diastolic blood pressure, and heart rate were
examined by an electronic blood pressure monitor
(Accutorr Plus, Datascope). Blood pressure measurement
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Systolic and diastolic blood pressure were obtained over
the brachial artery region with the arm supported at heart
level using appropriate sized cuff. The average of two mea-
surements taken with a 1-min interval between them was
recorded for analysis. Waist circumference was measured
midway between the lowest rib and the superior border of
the iliac crest using an inelastic measuring tape on the
bare skin and recorded to the nearest 0.1 cm. The tape
was snugged horizontally around the abdomen passing
across the navel without causing compression on the skin.
Measurement was performed at the end of normal expir-
ation. Measurements of blood pressure and waist circum-
ference were conducted by a trained research personnel.
Biochemical measurements were performed on fasting
plasma harvested from venous blood samples collected
after an overnight (a minimum of 10 hours) fast by cer-
tified phlebotomists. Plasma glucose, triglycerides, and
HDL-cholesterol concentrations were measured by an
accredited medical laboratory by commercial test kit
methods using an automatic clinical chemistry analyzer
(Architect CI8200, Abbott Diagnostics).
Data analyses
Data are expressed as mean ± standard deviation. Chi-
square test was performed to examine categorical data.
Mixed design repeated measure analysis of co-variance
(ANCOVA) with a 2 × 3 (yoga intervention × time)Table 1 Summary of the frequency and distribution of diagno
participants screened
Age
Gender
No. of subjects had 0 MetS component
No. of subjects had 1 MetS component
No. of subjects had 2 MetS components
No. of subjects had 3 MetS components
No. of subjects had 4 MetS components
No. of subjects had 5 MetS components
No. of subjects had central obesity
No. of subjects had high systolic blood pressure
No. of subjects had high diastolic blood pressure
No. of subjects had elevated plasma glucose
No. of subjects had elevated plasma triglyceride
No. of subjects had reduced HDL-cholesterol
According to the diagnostic guideline of NCEP ATP III criteria, an individual is diagn
1) central obesity (waist circumference exceeds 90 cm or 80 cm for Asian male and
than 130 mmHg or diastolic pressure equals to or is greater than 85 mmHg), 3) ele
100 mg/dL), 4) elevated blood triglyceride (blood triglyceride level equals to or ex
(HDL-C; level equals or is less than 40 mg/dL for male and 50 mg/dL for female). N
blood pressure, elevated blood glucose, elevated triglyceride, and reduced HDL-choles
100% because subjects had multiple MetS components.model was used to analyze the quantitative data. The
changes of measured parameters at Mid and Post re-
lative to Pre in control and yoga groups were analyzed
by independent t-test. Both per protocol analysis (PP)
and intention-to-treat analysis (ITT) were performed.
Intention-to-treat analysis was conducted by following
a publish protocol with multiple imputation procedure
[16]. All statistical analyses were performed using the
Statistical Package for the Social Sciences (SPSS) ver-
sion 21 for Windows. Statistical significance was ac-
cepted at p < 0.05.
Results
A total of 3,967 volunteers were screened for metabolic
syndrome (MetS), in which MetS was diagnosed in 1,081
subjects (27.2%). Central obesity and high systolic blood
pressure were found to be the most common MetS com-
ponents, being present in ~50% of the screened partici-
pants (Table 1). High diastolic blood pressure, elevated
plasma glucose and triglycerides, and low HDL-C were
found in 22-24% of the screened participants (Table 1).
After evaluation of subject’s information for inclusion
and exclusion criteria, 182 invited subjects successfully
completed the 1-year study (n = 84 in yoga group and n =
98 in the control group) (Figure 2). No significant differ-
ence was found in the baseline subject characteristics be-
tween yoga and control groups (Table 2). Our Chi-square
analysis demonstrated that the change of the number ofstic components for MetS in the 3,967 community-based
Participants screened (n = 3,967)
55.3 ± 10.7 (range 18 to 94) years
957 male & 3,010 female
891 (22.5%)
MetS-negative1,084 (27.3%)
911 (23.0%)
627 (15.8%)
MetS-positive355 (8.9%)
99 (2.5%)
1,884 (47.5%)
1,974 (49.8%)
883 (22.3%)
885 (22.3%)
934 (23.5%)
947 (23.9%)
osed with MetS when acquiring three or more of following conditions:
female, respectively), 2) hypertension (systolic pressure equals to or is greater
vated blood glucose (fasting plasma glucose level equals to or is higher than
ceeds 150 mg/dL), and 5) low level of high-density lipoprotein-cholesterol
otably, the numbers of subjects had central obesity, high systolic and diastolic
terol do not add up to the total number of participants screened (i.e., 3,967) and
Table 2 Baseline comparison of subject characteristics in Control and Yoga groups
Control group (n = 98) Yoga group (n = 84) P-value
Age 55.7 ± 9.4 56.3 ± 8.8 0.368
Gender 23 male, 75 female 24 male, 60 female 0.433
Waist circumference (cm) 89.2 ± 6.3 89.9 ± 7.7 0.523
Systolic blood pressure (mmHg) 132.8 ± 17.8 135.0 ± 15.5 0.376
Diastolic blood pressure (mmHg) 81.3 ± 10.5 83.6 ± 9.0 0.121
Fasting plasma glucose (mmol/L) 5.8 ± 1.0 5.7 ± 1.3 0.164
Fasting plasma triglycerides (mmol/L) 2.4 ± 2.2 2.0 ± 1.0 0.164
Fasting plasma HDL-C (mmol/L) 1.2 ± 0.3 1.2 ± 0.2 0.742
Resting heart rate (beat/min) 71.0 ± 8.6 71.2 ± 10.0 0.792
IPAQ activity (MET-min/week) 2857.6 ± 4953.4 3629.8 ± 2735.7 0.444
IPAQ sitting (min/week) 2291.6 ± 1494.5 2485.2 ± 1563.3 0.973
Average daily calories intake (kcal) 2313.0 ± 984.4 2293.6 ± 815.8 0.922
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was significantly associated with the yoga intervention
(P = 0.026) (Table 3). Indeed, 44% (37/84) of the subjects
no longer met the MetS diagnostic threshold at the end
of the 1-year yoga intervention (Table 3). In yoga group,
67% of the subjects (56/84) had decreased number of
MetS components whereas 15% (13/84) of the subjects
had increased number of MetS components after the
1-year experimental period (Table 3). Similar signifi-
cant results are obtained by using the intention-to-treat
analysis (P = 0.02).
We further examined the change in each individual
component to assess if it improved to the extent that it
no longer met the MetS defining criterion after the 1-
year intervention. As can be seen in Table 3, improve-
ments were seen in all MetS components, but only the
decrease in prevalence of central obesity (90.5% to 64.3%
at the end of the intervention) reached statistical signifi-
cance (P = 0.018). However, this change was not found
to reach the statistical significance under the intention-
to-treat analysis.
According to our mixed design repeated measures
ANCOVA analysis, yoga intervention was found to signifi-
cantly reduce the waist circumference (interaction effect:
yoga intervention × time, P = 0.003) which was co-varied
with the IPAQ activity index (interaction effect: Change in
IPAQ activity × time, P = 0.024) (Table 4). The results
of intention-to-treat analysis led to similar conclusions
(interaction effect: yoga intervention × time, P = 0.041,
interaction effect: Change in IPAQ activity × time, P =
0.001). A trend was observed for yoga intervention to
decrease the systolic blood pressure (interaction effect:
yoga intervention × time, P = 0.067) in per protocol ana-
lysis but not in intention-to-treat analysis (Table 4). Our
analysis revealed that yoga intervention significantly de-
creased the resting heart rate (interaction effect: yoga
intervention × time, P = 0.039) which was co-varied withthe IPAQ activity index (interaction effect: Change in
IPAQ activity × time, P = 0.001) (Table 4), however, the
significant change in resting heart rate was not found in
the analysis of intention-to-treat. No significant changes
of depression level and quality of life index were observed
(Table 4). The summarized changes of measured parame-
ters at 6-months (Mid) and 12-months (Post) relative to
baseline (Pre) in yoga and control groups were shown in
Table 5. No significant changes in the dietary pattern on
carbohydrate, protein, dietary fiber, soluble fiber, sugar, fat,
and cholesterol at baseline and completion of the 1-year
experimental period were observed in yoga and control
groups (Table 6).
Discussion
Metabolic syndrome (MetS) is generally diagnosed by
the presence of characteristics that include abdominal
obesity, high blood pressure, hyperglycemia, hypertri-
glyceridemia, and low high-density lipoprotein (HDL)-
cholesterol, with thresholds based on the definitions of
different professional bodies such as National Choles-
terol Education Program (NCEP) and International Dia-
betes Federation (IDF) [4,17]. Prevalence of MetS had
been continuously increasing over the past decades and
has reached epidemic proportions. In the United States,
prevalence of MetS in adults increased from 23.7% in
1988–1994 [18] to 34.5% in 1999–2002 [19] based on
the data of National Health and Nutrition Examination
Survey (NHANES). In Hong Kong, the prevalence of
MetS has also increased, from 9% in the early 1990s
(based on data obtained from 1,513 Chinese aged 18–66
years) to 23% in 2001–2002 (based on data obtained
from 7,473 community-based Chinese aged 19–93 years)
[20,21]. In the present study, 3,967 community-based
Chinese adults aged 18–94 years were screened for MetS
between 2010 and 2012. Our results demonstrated that
the prevalence of MetS has further increased to 27%
Table 3 Summary of the frequency and distribution of diagnostic components for MetS at baseline (Pre), midway (Mid), and completion (Post) of the 1-year
experimental period in Control and Yoga groups
Control group (n=98 for PP, n=137
for ITT)
Yoga group (n=84 for PP, n=146
for ITT) P-value Effect size P-value Effect size
Age 55.7 ± 9.4 (range 37 to 77) years 56.3 ± 8.8 (range 38 to 75) years (PP) (PP) (ITT) (ITT)
No. of subjects recovered from MetS after 1-yr (i.e., < 3 components) 34 37 0.197 0.061 0.150 0.064
No. of subjects had increased no. of MetS components after 1-yr 13 13
0.026* 0.146 0.020* 0.134No. of subjects had unchanged no. of MetS component after 1-yr 35 15
No. of subjects had decreased no. of MetS components after 1-yr 50 56
Pre Mid Post Pre Mid Post
No. of subjects had 0 MetS component 0 (0%) 1 (1.0%) 4 (4.1%) 0 (0%) 1 (1.2%) 4 (4.8%) - - - -
No. of subjects had 1 MetS component 0 (0%) 8 (8.2%) 9 (9.2%) 0 (0%) 10 (11.9%) 11 (13.1%) - - - -
No. of subjects had 2 MetS components 0 (0%) 25 (25.5%) 21 (21.4%) 0 (0%) 16 (19.1%) 22 (26.2%) - - - -
No. of subjects had 3 MetS components 55 (56.1%) 26 (26.5%) 32 (32.6%) 50 (59.5%) 35 (41.7%) 26 (31.0%) - - - -
No. of subjects had 4 MetS components 32 (32.6%) 30 (30.6%) 25 (25.5%) 26 (31.0%) 21 (25.0%) 20 (23.8%) - - - -
No. of subjects had 5 MetS components 11 (11.2%) 8 (8.2%) 7 (7.1%) 8 (9.5%) 1 (1.2%) 1 (1.2%) - - - -
No. of subjects had central obesity 93 (94.9%) 77 (78.6%) 80 (81.6%) 76 (90.5%) 66 (78.6%) 54 (64.3%) 0.018** 0.145 0.279 0.378
No. of subjects had high systolic blood pressure 61 (62.2%) 54 (55.1%) 49 (50.0%) 52 (61.9%) 43 (51.2%) 40 (47.6%) 0.497 0.045 0.463 0.358
No. of subjects had high diastolic blood pressure 41 (41.8%) 36 (36.7%) 33 (33.7%) 39 (46.4%) 25 (29.8%) 27 (32.1%) 0.428 0.063 0.491 0.346
No. of subjects had elevated fasting plasma glucose 48 (49.0%) 42 (42.9%) 34 (34.7%) 43 (51.2%) 38 (45.2%) 32 (38.1%) 0.644 0.034 0.512 0.359
No. of subjects had elevated fasting plasma triglycerides 72 (73.5%) 60 (61.2%) 60 (61.2%) 52 (61.9%) 48 (57.1%) 42 (50.0%) 0.758 0.019 0.372 0.362
No. of subjects had low plasma HDL-cholesterol 67 (68.4%) 55 (56.1%) 55 (56.1%) 57 (67.9%) 46 (54.8%) 44 (52.4%) 0.580 0.035 0.479 0.350
According to the diagnostic guideline of NCEP ATP III criteria, an individual is diagnosed with MetS when acquiring three or more of following conditions: 1) central obesity (waist circumference exceeds 90 cm or
80 cm for Asian male and female, respectively), 2) hypertension (systolic pressure equals to or is greater than 130 mmHg or diastolic pressure equals to or is greater than 85 mmHg), 3) elevated blood glucose (fasting
plasma glucose level equals to or is higher than 100 mg/dL), 4) elevated blood triglyceride (blood triglyceride level equals to or exceeds 150 mg/dL), and 5) low level of high-density lipoprotein-cholesterol (HDL-C;
level equals or is less than 40 mg/dL for male and 50 mg/dL for female). *Change of no. of MetS components after 1-yr experimental period (increased, unchanged or decreased) was significantly associated with
the intervention (yoga or control), **Diagnostic change of the presence of central obesity after 1-yr experimental period (still fulfilled the MetS criterion as central obesity or no longer met with the MetS criterion as
central obesity) was significantly associated with the intervention (yoga or control) according to our Chi-square analysis. PP; per protocol analysis, ITT; intention-to-treat analysis.
Siu
et
al.D
iabetology
&
M
etabolic
Syndrom
e
 (2015) 7:40 
Page
7
of
12
Table 4 Summary of the changes of waist circumference, systolic and diastolic blood pressure, fasting plasma glucose, triglycerides, high density lipoprotein
cholesterol (HDL-C), heart rate, and International Physical Activity Question (IPAQ) activity and sitting levels at baseline (Pre), midway (Mid), and completion
(Post) of the 1-year experimental period in Control and Yoga groups
Control group (n=98 for PP, n=137 for ITT) Yoga group (n=84 for PP, n=146 for ITT)
Pre Mid Post Pre Mid Post P-value(PP)
Effect size
(PP)
P-value
(ITT)
Effect size
(ITT)
Waist circumference (cm) 89.2 ± 6.3 87.4 ± 7.0 89.5 ± 7.6 89.9 ± 7.7 87.78 ± 8.3 86.8 ± 6.9
0.003# 0.010 0.041# 0.005
0.024## 0.027 0.001## 0.019
Systolic pressure (mmHg) 132.8 ± 17.8 131.5 ± 17.0 130.2 ± 18.1 135.0 ± 15.5 129.1 ± 13.8 128.5 ± 13.8 0.067 0.021 0.001## 0.019
Diastolic pressure (mmHg) 81.3 ± 10.5 80.4 ± 9.8 79.7 ± 10.1 83.6 ± 9.0 79.8 ± 9.6 80.0 ± 10.4 0.107 0.019 0.001### 0.012
Fasting plasma glucose (mmol/L) 5.8 ± 1.0 5.6 ± 0.9 5.6 ± 1.2 5.7 ± 1.3 5.6 ± 1.4 5.5 ± 1.4 0.567 0.004 0.026### 0.002
Fasting plasma triglycerides (mmol/L) 2.4 ± 2.2 2.3 ± 2.1 2.1 ± 1.2 2.0 ± 1.0 2.0 ± 1.3 1.8 ± 0.7 0.891 0.007 0.007### 0.009
Fasting plasma HDL-C (mmol/L) 1.2 ± 0.3 1.2 ± 0.3 1.2 ± 0.3 1.2 ± 0.2 1.2 ± 0.2 1.2 ± 0.2 0.567 0.003 0.031### 0.003
Resting heart rate (beats/min) 71.0 ± 8.6 71.3 ± 10.8 71.0 ± 10.7 71.2 ± 10.0 70.9 ± 8.3 67.8 ± 7.5
0.039# 0.006
0.016###
0.003
0.001## 0.011 0.005
IPAQ activity (MET-minutes/week) 2857.6 ± 4953.4 2607.8 ± 2064.3 3386.6 ± 3745.9 3629.8 ± 2735.7 3608.9 ± 4223.0 3977.7 ± 3946.4 0.051 0.009 0.001### 0.021
IPAQ sitting (minutes/week) 2291.6 ± 1494.5 2101.1 ± 1479.7 1973.0 ± 1517.8 2485.2 ± 1563.3 2256.1 ± 1223.6 2233.3 ± 1274.7 0.004### 0.014 0.044### 0.009
SF-12-PCS 46.64 ± 6.99 47.01 ± 7.98 47.00 ± 8.21 44.06 ± 8.02 47.21 ± 7.54 47.20 ± 7.94 0.031### 0.010 0.039### 0.015
SF-12-MCS 52.30 ± 8.16 51.21 ± 8.30 52.09 ±6.80 50.58 ± 8.84 51.01 ± 8.97 51.76 ±8.70 0.268 0.003 0.073 0.005
CES-D 11.62 ± 7.23 11.77 ± 6.58 10.47 ± 6.64 12.58 ± 7.86 11.85 ± 7.37 12.38 ± 8.53 0.179 0.001 0.631 0.001
#Significant interaction effect existed between yoga intervention and time, ##Significant interaction effect existed between the change in IPAQ activity and time according to our mixed design repeated measure
analysis of co-variance (ANCOVA) with a 2 × 3 (Change in IPAQ × time) model. ###Significant main effect of time existed according to our mixed design repeated measure analysis of variance (ANOVA) with a 2 × 3
(yoga intervention × time) model. PP; per protocol analysis, ITT; intention-to-treat analysis.
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Table 5 Summary of the changes in waist circumference, systolic and diastolic blood pressure, fasting plasma glucose, triglycerides, HDL-C, resting heart rate, IPAQ
activity and sitting indices, and average daily calories intake at Mid and Post when compared to Pre in Control and Yoga groups
Mid compared to Pre Post compared to Pre
Control group Yoga group P-value
(PP)
Effect size
(PP)
P-value
(ITT)
Effect size
(PP)
Control group Yoga group P-value
(PP)
Effect size
(PP)
P-value
(ITT)
Effect size
(ITT)
Change in waist
circumference (cm)
-1.78 ± 5.54 -2.09 ± 5.11 0.693 0.152 0.364 0.152 +0.37 ± 9.50 -3.07 ± 6.12 0.005* 0.444 0.022* 0.326
Change in systolic blood
pressure (mmHg)
-1.27 ± 13.49 -5.90 ± 13.73 0.023* 0.230 0..08 0.241 -2.63 ± 16.82 -6.50 ± 14.36 0.100 0.235 0.145 0.208
Change in diastolic
blood pressure (mmHg)
-1.76 ± 12.67 -3.82 ± 9.30 0.218 0.290 0.765 0.261 -1.60 ± 9.91 -3.58 ± 10.51 0.193 0.180 0.242 0.172
Change in fasting plasma
glucose (mmol/L)
-0.10 ± 0.72 -0.16 ± 0.57 0.551 0.066 0.724 0.057 -0.14 ± 0.98 -0.09 ± 0.61 0.659 0.065 0.515 0.097
Change in fasting plasma
triglycerides (mmol/L)
-0.08 ± 1.40 -0.02 ± 0.83 0.744 0.045 0.744 0.044 -0.28 ± 1.47 -0.21 ± 0.78 0.703 0.046 0.692 0.059
Change in fasting plasma
HDL-C (mmol/L)
+0.02 ± 0.22 +0.01 ± 0.16 0.532 0.085 0.537 0.090 +0.06 ± 0.30 +0.03± 0.15 0.338 0.128 0.495 0.094
Change in resting heart
rate (beat/min)
+0.44 ± 10.31 -0.57 ± 8.00 0.466 0.006 0.648 0.274 -0.02 ± 10.09 -3.52 ± 6.72 0.006* 0.057 0.698 0.218
Change in IPAQ activity
(MET-minutes/week)
-566.18 ± 5037.04 +98.71 ± 2203.14 0.264 0.252 0.476 0.127 +358.13 ±3598.22 +457.72 ± 2840.62 0.838 0.325 0.152 0.240
Change in IPAQ sitting
(minutes/week)
-284.64 ± 1318.65 -255.51 ± 1002.39 0.869 0.010 0.845 0.029 -347.86 ± 1560.47 -199.76 ± 1192.26 0.479 0.318 0.126 0.251
SF-12-PCS +0.61 ± 8.41 +3.41 ± 8.00 0.237 0.200 0.234 0.191 +1.72 ± 8.11 +3.41 ± 8.82 0.032* 0.341 0.044* 0.295
SF-12-MCS -1.67 ± 8.21 -0.49 ± 7.91 0.338 0.149 0.606 0.076 -0.78 ±7.41 -0.29 ± 7.42 0.685 0.068 0.504 0.063
CES-D +0.45 ± 6.75 -0.93 ± 6.17 0.182 0.214 0.385 0.129 -1.46 ± 7.73 -0.75 ± 6.88 0.555 0.098 0.511 0.102
Change in average daily
calories intake (kcal)
N/A N/A N/A N/A N/A N/A -126.45 ± 559.36 63.78 ± 879.94 0.244 0.246 0.244 0.246
*Significant difference existed in the changes between Yoga and Control groups. PP; per protocol analysis, ITT; intention-to-treat analysis.
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Table 6 Dietary pattern at baseline (Pre) and completion (Post) of the 1-year experimental period in Control and Yoga
groups
Control group (n = 40) Yoga group (n = 40)
Pre Post Pre Post P-value (PP) Effect size (PP)
Carbohydrate (g) 341.28 ± 147.59 396.57 ± 426.49 361.66 ± 148.16 363.00 ± 176.71 0.403 0.003
Protein (g) 104.16 ± 45.31 109.33 ± 75.82 117.78 ± 61.56 108.51 ± 45.39 0.785 0.001
Dietary fiber (g) 20.07 ± 9.13 22.24 ± 18.22 29.18 ± 54.19 20.78 ± 13.45 0.482 0.003
Soluble fiber (g) 1.85 ± 2.12 1.69 ± 2.01 3.30 ± 5.82 2.67 ± 2.89 0.423 0.003
Sugar (g) 57.65 ± 38.72 60.56 ± 54.65 61.65 ± 47.47 56.26 ± 62.42 0.891 0.001
Fat (g) 60.55 ± 71.20 61.15 ± 72.99 74.26 ± 117.91 49.92 ± 21.46 0.834 0.006
Cholesterol (g) 0.35 ± 0.26 0.29 ± 0.19 0.43 ± 0.50 0.34 ± 0.23 0.095 0.012
Siu et al. Diabetology & Metabolic Syndrome  (2015) 7:40 Page 10 of 12(notably all the aforementioned MetS percentages are
defined using the same set of diagnostic criteria, the
NCEP criteria, for valid comparison). These findings in-
disputably illustrate the growing and alarming preva-
lence of MetS in Hong Kong, which poses a serious
public health concern due to the strong link between
MetS, diabetes and cardiovascular disease. According to
the International Diabetes Federation (IDF), people with
MetS have a five-fold greater risk of developing type 2
diabetes and are three times as likely to have a heart at-
tack or stroke relative to people without MetS.
Taking the close relationship between MetS and dia-
betes as an example, the seriousness and importance of
the health problem resulting from MetS was highlighted
by Laaksonen and colleagues, who demonstrated that
the presence of MetS identified people at high risk for
developing diabetes, with odds ratios of 5.0 to 8.8 during
a 4-year follow-up in 1,005 Finnish middle-aged men
[22]. In the San Antonio Heart Study, MetS predicted
the incident rate of diabetes (11.3%) independently of
other risk factors such as fasting insulin and impaired
glucose tolerance during a 7- to 8-year follow-up in
1,734 participants [23]. Consistent with this, Cheung
and colleagues reported that 7.1% of subjects developed
diabetes after a 6-year follow-up in 1,679 Hong Kong
Chinese adults, and intriguingly these cases of incident
diabetes were found to be predicted by MetS at baseline
[24]. With the illustrated predictive strength of MetS for
diabetic occurrence, MetS can be taken as a warning sig-
nal for identifying individuals who are apparently healthy
but are susceptible to developing diabetes [24,25]. Our
finding of a MetS prevalence of 27% make it clear that
MetS has already become an epidemic in Hong Kong,
and will lead to increasing rates of diabetes in the com-
munity, with serious consequences at the personal, com-
munity and socioeconomic levels.
Prevention is the key for restraining the expanding
prevalence of MetS, and in those already with MetS.
Timely intervention can delay or arrest the progress
to the pathologic stage of diabetes and cardiovasculardiseases. More cost-effective and acceptable therapeutic
tools are needed to lessen the MetS epidemic. Among
the currently existing interventions, modification of life-
style remains the cornerstone for successful manage-
ment of MetS [6,7]. In regard to lifestyle modification,
regular physical activity has been indicated as one of the
crucial strategies [26]. Nonetheless, middle-aged and
older adult population, who are the age group with the
highest prevalence of MetS [18-21], may be unable to
adapt or be willing to participate in conventional physical
activities, such as running/jogging and gym-based resist-
ance training, but preferring other exercise modalities that
are less intense, flexible, and require no special equipment.
Yoga offers a suitable exercise option, and in this 1-year
intervention study, yoga was found to improve several
components of the MetS. According to our analyses, both
per protocol analysis and intention-to-treat analysis have
indicated that the reduction of the number of diagnostic
components for MetS was found to be significantly asso-
ciated with yoga intervention. Waist circumference was
significantly lower after the 1-year yoga intervention ac-
cording to both analyses of per protocol and intention-
to-treat. The systolic blood pressure decreased, though
the change did not reach statistical significance under per
protocol analysis. These results are consistent with the
findings of a recent systematic review and meta-analysis
that included 44 randomized controlled trials with a total
of 3,168 subjects exhibiting the clinically important effects
of yoga on most biological cardiovascular disease risk
factors [27].
Central obesity has been implicated as one of the most
important risk factors in the development of various
chronic diseases including diabetes mellitus and cardio-
vascular diseases. Recently, there has been increasing
data suggesting the favorable effects of yoga exercise
training on body weight and body composition (e.g.,
body fat percentage). Seo and co-workers reported that
8-weeks of yoga training intervention (performed three
times per week at intensity of 40-60% of heart rate re-
serve) significantly reduced body weight, body mass index,
Siu et al. Diabetology & Metabolic Syndrome  (2015) 7:40 Page 11 of 12fat mass and body fat percentage in obese boys (with body
mass index greater than the 95th percentile) aged 14.7 ±
0.5 years (n = 10) when compared to sedentary obese boys
in control group aged 14.6 ± 1.0 years (n = 10) [28]. In
addition, the observation that regular yoga training im-
proved the body weight and body composition was also
subsequently shown in obese postmenopausal women and
overweight/obese breast cancer survivors aged between
21–75 years [29,30]. Lee and colleagues demonstrated that
body weight, body mass index, lean body mass, body fat
percentage, visceral fat area, and waist circumference were
significantly decreased in healthy postmenopausal women
aged 54.5 ± 2.8 years with more than 36% body fat (N = 16)
after a 16-week yoga intervention [29]. Littman and col-
leagues have also shown that waist circumference was
reduced relatively more in women who were overweight/
obese (body mass index over 24 kg/m2) and breast cancer
survivors (n = 63) after 6-months of yoga intervention
with 5 yoga practice sessions per week when compared to
control subjects [30]. Our present findings of the effects of
1-year of regular yoga training on the improvement of
waist circumference have extended the evidence that yoga
has favorable effects on body composition in middle-aged
and older adults with MetS. The positive effects of yoga
intervention clinical trials on weight-related outcome
measures such as body mass index, body weight, percent
body fat, fat mass, waist circumference, hip circumference,
waist-to-hip ratio, and lean mass have recently been
reviewed [31]. Yoga exercise training is concluded to be
an appropriate and potentially successful lifestyle inter-
vention for weight maintenance, prevention of obesity,
and risk reduction for obesity-associated diseases, findings
which are further supported by the data presented here
and obtained from a reasonably large sample size of
middle-aged and older people with MetS and a long ex-
perimental study period (i.e., 1-year).
Our observations in regard to the beneficial effects of
yoga on blood pressure are in accordance with the previ-
ous findings. Singh and coworkers demonstrated signifi-
cant decreases in systolic and diastolic blood pressure
(systolic blood pressure decreased from 142 ± 3.9 to
126 ± 3.2 mmHg; diastolic blood pressure decreased
from 86.7 ± 2.5 to 75.5 ± 2.1 mmHg) in 24 type 2 dia-
betic patients after 40-days of yoga intervention under
guidance lasting for 30–40 minutes per day [32]. Cohen
and colleagues have shown a trend (P = 0.07) towards
reduction of systolic blood pressure in underactive,
overweight adult men and women with MetS following
10-weeks of regular yoga training intervention (systolic
blood pressure change through the 10-week study
period: −3.6 ± 13.9 mmHg in yoga group vs. +5.6 ±
9.3 mmHg in control group, n = 12 in each group) [14].
Besides, a recent randomized controlled trial demon-
strated a significant improvement of systolic bloodpressure in women aged 30–60 years with MetS follow-
ing 12-weeks of yoga exercise (systolic blood pressure
change through the 12-week study period: −3.5 ±
13.7 mmHg in yoga group, n = 20 vs. +2.0 ± 14.7 mmHg
in control group, n = 21) [28]. Furthermore, a recent
systematic review concluded that yoga is an effective ad-
junct therapy for hypertension based on the published
studies involving a total of 6,693 subjects [29]. In the
present study, our results support the use of yoga to
lower systolic blood pressure in middle-aged and older
people with MetS. While the change was modest (aver-
age decrease of 6.5 mmHg), even small decreases in
blood pressure have a significant effect on risk of car-
diovascular disease and stroke. Notably, the decreasing
trend of systolic blood pressure was only observed in
per protocol analysis but not intention-to-treat analysis,
suggesting that the effects of yoga exercise on systolic
blood pressure might depend on the dosage of the inter-
vention and/or subject compliance to the intervention.
A control trial in 2014 has demonstrated that the com-
pliance can affect the beneficial effects of yoga interven-
tion on systolic blood pressure. In this study subjects
diagnosed with hypertension were assigned to yoga class
group (12-week of yoga intervention with one 60-min
session per week with advance yoga technique and en-
courage to perform a 30-min yoga exercise at home
every day) and yoga home group (no yoga class but en-
courage to perform a 15-min yoga exercise at home
every day). Intriguingly, the decrease in systolic pressure
was only observed in the yoga home group but not in
the yoga class group. The researchers suspected that it
was because the participants in yoga class group per-
formed fewer yoga sessions compared to the participants
in the yoga home group due to barriers including the ad-
vanced exercises and the traveling to the class center,
causing lower compliance in the yoga class group [33].
In conclusion, the reduction of the number of diagnos-
tic components for MetS was found to be significantly
associated with yoga intervention. Waist circumference
was improved after the 1-year yoga intervention, while
systolic blood pressure tended to be improved following
yoga intervention. These results support the beneficial
effects of yoga training on the cardiovascular risk factor
diagnostic parameters of MetS in middle-aged and older
adults. These findings provide scientific evidence on the
therapeutic role of yoga in managing MetS. As yoga ex-
ercise is an economical regimen which can be easily and
readily applied to a large scale of target population, it is
of practical usefulness to relieve the burden of cardiovas-
cular disease and diabetes by alleviating the public health
epidemic of MetS. One of the limitations of the present
study is that there is no active control group in the study
design. It is not known whether the establishment of
a regular exercise habit and regular group gathering
Siu et al. Diabetology & Metabolic Syndrome  (2015) 7:40 Page 12 of 12might contribute a portion of the beneficial effects to
our examined outcome measures due to the change of
the exercise habit and social life other than the yoga
intervention and it remains to be further elucidated.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
PMS designed the study, acquired and interpreted data, contributed to the
discussion, wrote the manuscript, and reviewed/edited the manuscript. APY
researched data. IFB researched data, contributed to the discussion, and
reviewed/edited the manuscript. JW contributed to the discussion, and
reviewed/edited the manuscript. All authors read and approved the final
manuscript.
Acknowledgements
This study was funded by the Hong Kong Jockey Club Charities Trust.
The authors gratefully acknowledge all the participants for their kind
contributions to this study. The authors also thank the yoga instructors, Ms
Ingrid Lam and Ms Sophia Kwok, for their contribution to the delivery of the
yoga classes in the study.
Author details
1Department of Health Technology and Informatics, Faculty of Health
and Social Sciences, The Hong Kong Polytechnic University, Hung Hom,
Hong Kong, China. 2Department of Medicine and Therapeutics, Faculty of
Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong, China.
Received: 12 November 2014 Accepted: 14 April 2015
References
1. Alberti KG, Zimmet P, Shaw J, Group IDFETFC. The metabolic syndrome–a
new worldwide definition. Lancet. 2005;366:1059–62.
2. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes
mellitus and its complications. Part 1: diagnosis and classification of
diabetes mellitus provisional report of a WHO consultation. Diabet Med.
1998;15:539–53.
3. Balkau B, Charles MA. Comment on the provisional report from the WHO
consultation. European Group for the Study of Insulin Resistance (EGIR).
Diabet Med. 1999;16:442–3.
4. Expert Panel on Detection E, Treatment of High Blood Cholesterol in A.
Executive Summary of The Third Report of The National Cholesterol
Education Program (NCEP). Expert Panel on Detection, Evaluation, And
Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).
JAMA. 2001;285:2486–97.
5. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al.
Diagnosis and management of the metabolic syndrome: an American Heart
Association/National Heart, Lung, and Blood Institute Scientific Statement.
Circulation. 2005;112:2735–52.
6. Fappa E, Yannakoulia M, Pitsavos C, Skoumas I, Valourdou S, Stefanadis C.
Lifestyle intervention in the management of metabolic syndrome: could we
improve adherence issues? Nutrition. 2008;24:286–91.
7. Pitsavos C, Panagiotakos D, Weinem M, Stefanadis C. Diet, exercise and the
metabolic syndrome. Rev Diabet Stud. 2006;3:118–26.
8. Stanescu DC, Nemery B, Veriter C, Marechal C. Pattern of breathing and
ventilatory response to CO2 in subjects practicing hatha-yoga. J Appl Physiol
Respir Environ Exerc Physiol. 1981;51:1625–9.
9. Miyamura M, Nishimura K, Ishida K, Katayama K, Shimaoka M, Hiruta S. Is
man able to breathe once a minute for an hour?: the effect of yoga
respiration on blood gases. Jpn J Physiol. 2002;52:313–6.
10. Anand MP. Non-pharmacological management of essential hypertension.
J Indian Med Assoc. 1999;97:220–5.
11. Waelde LC, Thompson L, Gallagher-Thompson D. A pilot study of a yoga
and meditation intervention for dementia caregiver stress. J Clin Psychol.
2004;60:677–87.
12. Woolery A, Myers H, Sternlieb B, Zeltzer L. A yoga intervention for young
adults with elevated symptoms of depression. Altern Ther Health Med.
2004;10:60–3.13. Khatri D, Mathur KC, Gahlot S, Jain S, Agrawal RP. Effects of yoga and
meditation on clinical and biochemical parameters of metabolic syndrome.
Diabetes Res Clin Pract. 2007;78:e9–10.
14. Cohen BE, Chang AA, Grady D, Kanaya AM. Restorative yoga in adults with
metabolic syndrome: a randomized, controlled pilot trial. Metab Syndr Relat
Disord. 2008;6:223–9.
15. DiBenedetto M, Innes KE, Taylor AG, Rodeheaver PF, Boxer JA, Wright HJ,
et al. Effect of a gentle Iyengar yoga program on gait in the elderly: an
exploratory study. Arch Phys Med Rehabil. 2005;86:1830–7.
16. Schiattino I, Villegas R, Cruzat A, Cuenca J, Salazar L, Aravena O, et al.
Multiple imputation procedures allow the rescue of missing data: an
application to determine serum tumor necrosis factor (TNF) concentration
values during the treatment of rheumatoid arthritis patients with anti-TNF
therapy. Biol Res. 2005;38:7–12.
17. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome–a new world-wide definition.
A Consensus Statement from the International Diabetes Federation. Diabet Med.
2006;23:469–80.
18. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among
US adults: findings from the third National Health and Nutrition
Examination Survey. JAMA. 2002;287:356–9.
19. Ford ES. Prevalence of the metabolic syndrome defined by the International
Diabetes Federation among adults in the U.S. Diabetes Care.
2005;28:2745–9.
20. Ko GT, Cockram CS, Chow CC, Yeung V, Chan WB, So WY, et al. High
prevalence of metabolic syndrome in Hong Kong Chinese–comparison of
three diagnostic criteria. Diabetes Res Clin Pract. 2005;69:160–8.
21. Ko GT, Tang JS. Metabolic syndrome in the Hong Kong community: the
United Christian Nethersole Community Health Service primary healthcare
programme 2001–2002. Singap Med J. 2007;48:1111–6.
22. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA.
Metabolic syndrome and development of diabetes mellitus: application and
validation of recently suggested definitions of the metabolic syndrome in a
prospective cohort study. Am J Epidemiol. 2002;156:1070–7.
23. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM, San Antonio Heart
S. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio
heart study. Diabetes Care. 2003;26:3153–9.
24. Cheung BM, Wat NM, Man YB, Tam S, Thomas GN, Leung GM, et al.
Development of diabetes in Chinese with the metabolic syndrome: a 6-year
prospective study. Diabetes Care. 2007;30:1430–6.
25. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al.
Cardiovascular morbidity and mortality associated with the metabolic
syndrome. Diabetes Care. 2001;24:683–9.
26. Lakka TA, Laaksonen DE. Physical activity in prevention and treatment of
the metabolic syndrome. Appl Physiol Nutr Metab. 2007;32:76–88.
27. Cramer H, Lauche R, Haller H, Steckhan N, Michalsen A, Dobos G. Effects of
yoga on cardiovascular disease risk factors: a systematic review and
meta-analysis. Int J Cardiol. 2014;173:170–83.
28. Seo DY, Lee S, Figueroa A, Kim HK, Baek YH, Kwak YS, et al. Yoga training
improves metabolic parameters in obese boys. Korean J Physiol Pharmacol.
2012;16:175–80.
29. Lee JA, Kim JW, Kim DY. Effects of yoga exercise on serum adiponectin and
metabolic syndrome factors in obese postmenopausal women. Menopause.
2012;19:296–301.
30. Littman AJ, Bertram LC, Ceballos R, Ulrich CM, Ramaprasad J, McGregor B,
et al. Randomized controlled pilot trial of yoga in overweight and obese
breast cancer survivors: effects on quality of life and anthropometric
measures. Support Care Cancer. 2012;20:267–77.
31. Rioux JG, Ritenbaugh C. Narrative review of yoga intervention clinical trials
including weight-related outcomes. Altern Ther Health Med. 2013;19:32–46.
32. Singh S, Malhotra V, Singh KP, Madhu SV, Tandon OP. Role of yoga in
modifying certain cardiovascular functions in type 2 diabetic patients.
J AssocPhysicians India. 2004;52:203–6.
33. Wolff M, Sundquist K, Larsson Lonn S, Midlov P. Impact of yoga on blood
pressure and quality of life in patients with hypertension - a controlled trial
in primary care, matched for systolic blood pressure. BMC Cardiovasc Disord.
2013;13:111.
